Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tolerability, pharmacokinetic and pharmacodynamic assessment of teriparatide nasal spray versus subcutaneous teriparatide in postmenopausal female volunteers.

Next Previous
Trial Profile

Tolerability, pharmacokinetic and pharmacodynamic assessment of teriparatide nasal spray versus subcutaneous teriparatide in postmenopausal female volunteers.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 11 Nov 2010

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Teriparatide (Primary) ; Teriparatide
  • Indications Osteoporosis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics

Most Recent Events

  • 19 Oct 2010 Status changed from recruiting to completed.
  • 19 Oct 2010 Results presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research
  • 19 Oct 2010 Study title not official.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top